Google Search Trends About Systemic Psoriasis Treatment: What Do People Want to Know About Biologics and Janus Kinase Inhibitors?

Saved in:

Bibliographic Details
Main Authors:	Subin Lim (Author), Sarah Kooper-Johnson (Author), Courtney A Chau (Author), Claire Chen (Author), Fei-Shiuann Clarissa Yang (Author), Gabriela Cobos (Author)
Format:	Book
Published:	JMIR Publications, 2024-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Janus Kinase Inhibitors as Successful Treatment Alternative in Dupilumab-Induced Psoriasis
by: Lina Weiss, et al.
Published: (2024)

Antipruritic Effects of Janus Kinase Inhibitor Tofacitinib in a Mouse Model of Psoriasis
by: Takashi Hashimoto, et al.
Published: (2019)

DEMYSTIFYING DIGITAL SIGN OUT, EVERYTHING YOU WANT TO KNOW ABOUT TRANSITIONING INTO PIXELS
by: Giovanni M. Lujan, et al.
Published: (2022)

Itch and Janus Kinase Inhibitors
by: Yujin Han, et al.
Published: (2023)

Acneiform Lesions but not Acne after Treatment with Janus Kinase Inhibitors: Diagnosis and Management of Janus Kinase-acne
by: Fabienne Ballanger, et al.
Published: (2023)

Basics of Janus kinases: a review
by: Hanan R Nada, et al.
Published: (2020)

Janus kinase inhibitors: jackpot or potluck?
by: Pavithran Keechilat, et al.
Published: (2012)

Immunohistochemical study of janus kinase 1/signal transducer and activator of transcription 3 in psoriasis vulgaris
by: Farag AGA, et al.
Published: (2019)

What do coaches want to know about sports-related concussion? A needs assessment study
by: Lindsay Sullivan, et al.
Published: (2018)

Janus kinases: dermatological perspective, a review
by: Hanan R Nada, et al.
Published: (2020)

Janus Kinase inhibitors in dermatology: a review
by: Bárbara Vieira-Granja, et al.
Published: (2023)

Janus Associated Kinases Inhibitors in the Pharmacological Thera
by: Daniela Santos1, et al.
Published: (2017)

Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis
by: Vishal R. Tandon, et al.
Published: (2022)

What hypertensive patients want to know [and from whom] about their disease: a two-year longitudinal study
by: Erika R. Cappelletti, et al.
Published: (2020)

Trees You Want to Know
by: Peattie, Donald Culross, 1898-1964; Michaux, François André, 1770-1855 [Illustrator]; Taylor, Ethel Bonney [Illustrator]

Bullous pemphigoid treated with Janus kinase inhibitor upadacitinib
by: David Nash, BHSc, et al.
Published: (2023)

Role of janus kinase inhibitors in the treatment of alopecia areata
by: Triyangkulsri K, et al.
Published: (2018)

Janus kinase inhibitors - their current applications and future prospects
by: Natalia Wierzbowska, et al.
Published: (2022)

Janus kinase inhibitors: between prescription authorization and reimbursability
by: F.R. Spinelli, et al.
Published: (2023)

The role of janus kinases in the treatment of autoimmune skin diseases
by: Arnold Kukowka, et al.
Published: (2021)

The Upadacitinib - New Janus Kinase Inhibitor - Literature Review
by: Michalina Grzelka, et al.
Published: (2024)

Comprehensive kinase profile of pacritinib, a nonmyelosuppressive Janus kinase 2 inhibitor
by: Singer J, et al.
Published: (2016)

Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trials
by: Tatjana Welzel, et al.
Published: (2021)

What do health consumers want to know about childhood vaccination? An evaluation of data from an Australian medicines call centre
by: Marnix Mus, et al.
Published: (2017)

Leveraging Text Mining Approach to Identify What People Want to Know About Mental Disorders From Online Inquiry Platforms
by: Soowon Park, et al.
Published: (2021)

Correction to: Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trials
by: Tatjana Welzel, et al.
Published: (2021)

Geographic Disparities in Online Searches for Psoriasis Biologics in the United States: Google Trends Analysis
by: Annie Chang, et al.
Published: (2024)

EMERGING USE OF JANUS KINASE INHIBITORS FOR ORAL LICHEN PLANUS
by: Mihaela Paula Toader, et al.
Published: (2024)

Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disorders
by: Robert Roskoski, Jr
Published: (2022)

Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
by: Manuel Morgado, et al.
Published: (2017)

The Use of Janus Kinase Inhibitors in Axial Spondyloarthritis: Current Insights
by: Eric Toussirot
Published: (2022)

Immunohistochemistry of Janus Kinase 1 (JAK1) Expression in Vitiligo
by: Asmaa Gaber Abdou, et al.
Published: (2018)

The Importance of Knowing about Onychocryptosis
by: Denislaydy López Rodríguez, et al.
Published: (2016)

The Importance of Knowing about Onychocryptosis
by: Denislaydy López Rodríguez, et al.
Published: (2016)

Successful treatment of pyoderma gangrenosum with Janus kinase 1/2 inhibition
by: Sebastian Sitaru, et al.
Published: (2022)

Refractory mogamulizumab-associated rash responding to an oral Janus kinase inhibitor
by: Carine M. Lama, MS, et al.
Published: (2023)

Treatment of necrobiosis lipoidica with combination Janus kinase inhibition and intralesional corticosteroid
by: William Damsky, MD, PhD, et al.
Published: (2020)

Association of myalgias with compounded topical Janus kinase inhibitor use in vitiligo
by: Shanthi Narla, MD, et al.
Published: (2020)

Therapeutic Potential of Janus Kinase Inhibitors for the Management of Interstitial Lung Disease
by: Huo R, et al.
Published: (2022)

A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia
by: Yoshiya Tanaka
Published: (2023)